FITC荧光Anti-C3c抗体
FITC Anti-C3c antibody
4
(1 Review)
|
(16 Publications)
Rabbit Polyclonal C3 antibody - conjugated to FITC. Suitable for ICC/IF and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human C3.
查看别名
CPAMD1, C3, Complement C3, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - FITC Anti-C3c antibody (AB4212)
ICC/IF image of ab4212 stained HepG2 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab4212, 1μg/ml) overnight at +4°C. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
反应性数据
性能和储存信息
形式
纯度
纯化说明
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C3c functions as a by-product of complement activation and is associated with immune defense processes. It does not independently participate in the formation of the complement complex but results from the breakdown of C3 into C3b and other fragments. This fragment may play roles in modulating immune responses through its interaction with complement receptors. The presence of C3c marks the location and intensity of complement activation in tissue or circulation indirectly indicating the body's response to pathogens or damaged cells.
Pathways
The C3c fragment serves as an indirect marker within the complement cascade particularly signaling the involvement of the classical and alternative complement pathways. The generation of C3c follows the activation of these pathways highlighting the initial activation of C3 into active fragments such as C3b. Proteins related to these pathways include factors H and I which regulate C3b breakdown ensuring controlled progression of this immune response.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (16)
Recent publications for all applications. Explore the full list and refine your search
Haematologica : PubMed40820810
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2666 PubMed40102474
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:592 PubMed39147758
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:11020 PubMed38745067
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of dental sciences 18:1008-1015 PubMed37404619
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 10:891513 PubMed36860338
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of haematology 199:603-615 PubMed35864790
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 236:5012-5021 PubMed33400289
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 27:279-288 PubMed33335322
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience bulletin 35:661-672 PubMed30900142
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com